{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T17:30:05Z","timestamp":1763141405147,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12035-020-02072-4","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T06:02:55Z","timestamp":1597816975000},"page":"4921-4928","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A\u00a0Review on Neurobiological Insight of the Pandemic"],"prefix":"10.1007","volume":"57","author":[{"given":"Pooja","family":"Kaushik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medha","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabiha","family":"Parveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heena","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6318-6506","authenticated-orcid":false,"given":"Suhel","family":"Parvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,19]]},"reference":[{"key":"2072_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijid.2020.02.033","volume":"93","author":"S Zhang","year":"2020","unstructured":"Zhang S, Diao MY, Yu W, Pei L, Lin Z, Chen D (2020) Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: a data-driven analysis. Int J Infect Dis 93:201\u2013204. https:\/\/doi.org\/10.1016\/j.ijid.2020.02.033","journal-title":"Int J Infect Dis"},{"key":"2072_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17:181\u2013192. https:\/\/doi.org\/10.1038\/s41579-018-0118-9","journal-title":"Nat Rev Microbiol"},{"key":"2072_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens9030186","volume":"9","author":"HM Ashour","year":"2020","unstructured":"Ashour HM, Elkhatib WF, Rahman MM, Elshabrawy HA (2020) Insights into the recent 2019 novel coronavirus (Sars-coV-2) in light of past human coronavirus outbreaks. Pathogens 9:1\u201315. https:\/\/doi.org\/10.3390\/pathogens9030186","journal-title":"Pathogens"},{"key":"2072_CR4","doi-asserted-by":"publisher","first-page":"102523","DOI":"10.1016\/j.autrev.2020.102523","volume":"19","author":"EG Favalli","year":"2020","unstructured":"Favalli EG, Ingegnoli F, De Lucia O et al (2020) COVID-19 infection and rheumatoid arthritis: faraway, so close! Autoimmun Rev 19:102523. https:\/\/doi.org\/10.1016\/j.autrev.2020.102523","journal-title":"Autoimmun Rev"},{"key":"2072_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2174\/1570159x11311020007","volume":"11","author":"T Jiang","year":"2013","unstructured":"Jiang T, Gao L, Lu J, Zhang Y-D (2013) ACE2-Ang-(1-7)-Mas axis in brain: a potential target for prevention and treatment of ischemic stroke. Curr Neuropharmacol 11:209\u2013217. https:\/\/doi.org\/10.2174\/1570159x11311020007","journal-title":"Curr Neuropharmacol"},{"key":"2072_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/iid3.277","volume":"7","author":"BY Farris","year":"2019","unstructured":"Farris BY, Monaghan KL, Zheng W, Amend CD, Hu H, Ammer AG, Coad JE, Ren X et al (2019) Ischemic stroke alters immune cell niche and chemokine profile in mice independent of spontaneous bacterial infection. Immun Inflamm Dis 7:326\u2013341. https:\/\/doi.org\/10.1002\/iid3.277","journal-title":"Immun Inflamm Dis"},{"key":"2072_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.14336\/AD.2014.0500294","volume":"5","author":"DN Doll","year":"2014","unstructured":"Doll DN, Barr TL, Simpkins JW (2014) Cytokines: their role in stroke and potential use as biomarkers and therapeutic targets. Aging Dis 5:294\u2013306. https:\/\/doi.org\/10.14336\/AD.2014.0500294","journal-title":"Aging Dis"},{"key":"2072_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12974-014-0213-4","volume":"11","author":"PJ Winklewski","year":"2014","unstructured":"Winklewski PJ, Radkowski M, Demkow U (2014) Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke. J Neuroinflammation 11:4\u201311. https:\/\/doi.org\/10.1186\/s12974-014-0213-4","journal-title":"J Neuroinflammation"},{"key":"2072_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.micinf.2020.03.003","volume":"2","author":"Y Qiu","year":"2020","unstructured":"Qiu Y, Zhao YB, Wang Q, Li JY, Zhou ZJ, Liao CH, Ge XY (2020) Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2. Microbes Infect 2:221\u2013225. https:\/\/doi.org\/10.1016\/j.micinf.2020.03.003","journal-title":"Microbes Infect"},{"key":"2072_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.12688\/f1000research.22211.1","volume":"9","author":"RL Kruse","year":"2020","unstructured":"Kruse RL (2020) Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Res 9:72. https:\/\/doi.org\/10.12688\/f1000research.22211.1","journal-title":"F1000Res"},{"key":"2072_CR11","doi-asserted-by":"publisher","unstructured":"Lau K, Yu W, Chu C et al (2004) Infection by SARS Coronavirus. Emerg Infect Dis 10(2):342\u2013344. https:\/\/doi.org\/10.3201\/eid1002.030638","DOI":"10.3201\/eid1002.030638"},{"key":"2072_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.15537\/smj.2017.2.16255","volume":"38","author":"FM Al-Hameed","year":"2017","unstructured":"Al-Hameed FM (2017) Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus. Saudi Med J 38:196\u2013200. https:\/\/doi.org\/10.15537\/smj.2017.2.16255","journal-title":"Saudi Med J"},{"key":"2072_CR13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/infdis\/jiv499","volume":"212","author":"K Li","year":"2015","unstructured":"Li K, Wohlford-Lenane C, Perlman S, Zhao J, Jewell AK, Reznikov LR, Gibson-Corley KN, Meyerholz DK et al (2015) Middle east respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. J Infect Dis 212:712\u2013722. https:\/\/doi.org\/10.1093\/infdis\/jiv499","journal-title":"J Infect Dis"},{"key":"2072_CR14","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s15010-015-0720-y","volume":"43","author":"YM Arabi","year":"2015","unstructured":"Arabi YM, Harthi A, Hussein J, Bouchama A, Johani S, Hajeer AH, Saeed BT, Wahbi A et al (2015) Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV). Infection 43:495\u2013501. https:\/\/doi.org\/10.1007\/s15010-015-0720-y","journal-title":"Infection"},{"key":"2072_CR15","unstructured":"(2020) COVID-19 weekly surveillance report. 2020:2020"},{"key":"2072_CR16","unstructured":"74783607.\u00a0accessed 11-15th April, 2020. @ www.businessinsider.in"},{"key":"2072_CR17","doi-asserted-by":"publisher","first-page":"e01218","DOI":"10.1213\/xaa.0000000000001218","volume":"14","author":"WC Culp","year":"2020","unstructured":"Culp WC (2020) Coronavirus disease 2019. A A Pract 14:e01218. https:\/\/doi.org\/10.1213\/xaa.0000000000001218","journal-title":"A A Pract"},{"key":"2072_CR18","doi-asserted-by":"publisher","unstructured":"Lyden P (2020) Temporary emergency guidance to US stroke centers during the COVID-19 pandemic on behalf of the AHA\/ASA Stroke Council Leadership. Stroke 10. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030023","DOI":"10.1161\/STROKEAHA.120.030023"},{"key":"2072_CR19","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1161\/strokeaha.120.030335","volume":"51","author":"S Yaghi","year":"2020","unstructured":"Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, Henninger N, Trivedi T et al (2020) SARS-CoV-2 and stroke in a New York Healthcare System. Stroke 51:2002\u20132011. https:\/\/doi.org\/10.1161\/strokeaha.120.030335","journal-title":"Stroke"},{"key":"2072_CR20","unstructured":"3e23d100cd5cacbcf16cf4b56fe2eb158b84fd85.\u00a0accessed 11-15th April, 2020. @ www.neurologyadvisor.com"},{"key":"2072_CR21","doi-asserted-by":"publisher","unstructured":"Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, Wang D, Mao L et al (2020) Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol:1\u20136. https:\/\/doi.org\/10.1136\/svn-2020-000431","DOI":"10.1136\/svn-2020-000431"},{"key":"2072_CR22","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","volume":"27","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, Bucci E, Piacentini M et al (2020) COVID-19 infection: the perspectives on immune responses. Cell Death Differ 27:1451\u20131454. https:\/\/doi.org\/10.1038\/s41418-020-0530-3","journal-title":"Cell Death Differ"},{"key":"2072_CR23","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.18632\/aging.101931","volume":"11","author":"M Yousufuddin","year":"2019","unstructured":"Yousufuddin M, Young N (2019) Aging and ischemic stroke. Aging (Albany NY) 11:2542\u20132544. https:\/\/doi.org\/10.18632\/aging.101931","journal-title":"Aging (Albany NY)"},{"key":"2072_CR24","unstructured":"experts-suggest-roche-s-activase-as-a-potential-covid-19-drug.\u00a0accessed 11-15th April, 2020. @ www.fiercepharma.com"},{"key":"2072_CR25","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/jth.12363","volume":"11","author":"A Schmidt-Tanguy","year":"2013","unstructured":"Schmidt-Tanguy A, Voswinkel J, Henrion D, Subra JF, Loufrani L, Rohmer V, Ifrah N, Belizna C (2013) Antithrombotic effects of hydroxychloroquine in primary antiphospholipid syndrome patients. J Thromb Haemost 11:1927\u20131929. https:\/\/doi.org\/10.1111\/jth.12363","journal-title":"J Thromb Haemost"},{"key":"2072_CR26","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.autrev.2014.12.006","volume":"14","author":"C Belizna","year":"2015","unstructured":"Belizna C (2015) Hydroxychloroquine as an antithrombotic in antiphospholipid syndrome. Autoimmun Rev 14:358\u2013362. https:\/\/doi.org\/10.1016\/j.autrev.2014.12.006","journal-title":"Autoimmun Rev"},{"key":"2072_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.phrs.2017.06.016","volume":"125","author":"G Huber","year":"2017","unstructured":"Huber G, Schuster F, Raasch W (2017) Brain renin-angiotensin system in the pathophysiology of cardiovascular diseases. Pharmacol Res 125:72\u201390. https:\/\/doi.org\/10.1016\/j.phrs.2017.06.016","journal-title":"Pharmacol Res"},{"key":"2072_CR28","doi-asserted-by":"publisher","first-page":"R804","DOI":"10.1152\/ajpregu.00222.2010","volume":"300","author":"P Xu","year":"2011","unstructured":"Xu P, Sriramula S, Lazartigues E (2011) ACE2\/ANG-(1-7)\/Mas pathway in the brain: The axis of good. Am J Physiol Regul Integr Comp Physiol 300:R804\u2013R817. https:\/\/doi.org\/10.1152\/ajpregu.00222.2010","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2072_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1447-0594.2012.00900.x","volume":"13","author":"M Mogi","year":"2013","unstructured":"Mogi M, Horiuchi M (2013) Effect of angiotensin II type 2 receptor on stroke, cognitive impairment and neurodegenerative diseases. Geriatr Gerontol Int 13:13\u201318. https:\/\/doi.org\/10.1111\/j.1447-0594.2012.00900.x","journal-title":"Geriatr Gerontol Int"},{"key":"2072_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jns.2014.07.023","volume":"345","author":"J Zhao","year":"2014","unstructured":"Zhao J, Qin X, Li S, Zeng Z (2014) Association between the ACE I\/D polymorphism and risk of ischemic stroke: an updated meta-analysis of 47,026 subjects from 105 case-control studies. J Neurol Sci 345:37\u201347. https:\/\/doi.org\/10.1016\/j.jns.2014.07.023","journal-title":"J Neurol Sci"},{"key":"2072_CR31","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1476-5381.2010.01167.x","volume":"163","author":"M Horiuchi","year":"2011","unstructured":"Horiuchi M, Mogi M (2011) Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage. Br J Pharmacol 163:1122\u20131130. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01167.x","journal-title":"Br J Pharmacol"},{"key":"2072_CR32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/jid.2014.371","volume":"135","author":"H Sierra","year":"2015","unstructured":"Sierra H, Cordova M, Chen CSJ, Rajadhyaksha M (2015) Confocal imaging-guided laser ablation of basal cell carcinomas: an ex vivo study. J Invest Dermatol 135:612\u2013615. https:\/\/doi.org\/10.1038\/jid.2014.371","journal-title":"J Invest Dermatol"},{"key":"2072_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.redox.2017.09.016","volume":"14","author":"T Chen","year":"2018","unstructured":"Chen T, Dai SH, Li X, Luo P, Zhu J, Wang YH, Fei Z, Jiang XF (2018) Sirt1-Sirt3 axis regulates human blood-brain barrier permeability in response to ischemia. Redox Biol 14:229\u2013236. https:\/\/doi.org\/10.1016\/j.redox.2017.09.016","journal-title":"Redox Biol"},{"key":"2072_CR34","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.2174\/138161208786848739","volume":"14","author":"A Tuttolomondo","year":"2008","unstructured":"Tuttolomondo A, Di Raimondo D, di Sciacca R et al (2008) Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 14:3574\u20133589. https:\/\/doi.org\/10.2174\/138161208786848739","journal-title":"Curr Pharm Des"},{"key":"2072_CR35","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00011-009-0036-4","volume":"58","author":"AR Nayak","year":"2009","unstructured":"Nayak AR, Kashyap RS, Purohit HJ, Kabra D, Taori GM, Daginawala HF (2009) Evaluation of the inflammatory response in sera from acute ischemic stroke patients by measurement of IL-2 and IL-10. Inflamm Res 58:687\u2013691. https:\/\/doi.org\/10.1007\/s00011-009-0036-4","journal-title":"Inflamm Res"},{"key":"2072_CR36","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/jcbfm.2012.88","volume":"32","author":"KL Lambertsen","year":"2012","unstructured":"Lambertsen KL, Biber K, Finsen B (2012) Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab 32:1677\u20131698. https:\/\/doi.org\/10.1038\/jcbfm.2012.88","journal-title":"J Cereb Blood Flow Metab"},{"key":"2072_CR37","doi-asserted-by":"publisher","first-page":"209","DOI":"10.26402\/jpp.2019.2.04","volume":"70","author":"A Lasek-Bal","year":"2019","unstructured":"Lasek-Bal A, Jedrzejowska-Szypulka H, Student S et al (2019) The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J Physiol Pharmacol 70:209\u2013217. https:\/\/doi.org\/10.26402\/jpp.2019.2.04","journal-title":"J Physiol Pharmacol"},{"key":"2072_CR38","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1161\/01.STR.0000259709.16654.8f","volume":"38","author":"OB Dimitrijevic","year":"2007","unstructured":"Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV (2007) Absence of the chemokine receptor CCR2 protects against cerebral ischemia\/reperfusion injury in mice. Stroke 38:1345\u20131353. https:\/\/doi.org\/10.1161\/01.STR.0000259709.16654.8f","journal-title":"Stroke"},{"key":"2072_CR39","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/jcbfm.2011.49","volume":"31","author":"K Kuboyama","year":"2011","unstructured":"Kuboyama K, Harada H, Tozaki-Saitoh H, Tsuda M, Ushijima K, Inoue K (2011) Astrocytic P2Y1 receptor is involved in the regulation of cytokine\/chemokine transcription and cerebral damage in a rat model of cerebral ischemia. J Cereb Blood Flow Metab 31:1930\u20131941. https:\/\/doi.org\/10.1038\/jcbfm.2011.49","journal-title":"J Cereb Blood Flow Metab"},{"key":"2072_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5152\/eurasianjmed.2017.17022","volume":"49","author":"M Amin","year":"2017","unstructured":"Amin M, Vakilian A, Mahmoodi MH, Hassanshahi G, Falahati pour SK, Dolatabadi MR, Nadimi AE (2017) \u0130skemik inmeli hastalarda 1, 9 ve 10 CXC-kemokin ligandlar\u0131n\u0131n dola\u015f\u0131mdaki seviyelerinde art\u0131\u015f. Eurasian J Med 49:92\u201396. https:\/\/doi.org\/10.5152\/eurasianjmed.2017.17022","journal-title":"Eurasian J Med"},{"key":"2072_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-018-2164-0","volume":"22","author":"CS Samary","year":"2018","unstructured":"Samary CS, Ramos AB, Maia LA, Rocha NN, Santos CL, Magalh\u00e3es RF, Clevelario AL, Pimentel-Coelho PM et al (2018) Focal ischemic stroke leads to lung injury and reduces alveolar macrophage phagocytic capability in rats. Crit Care 22:1\u201311. https:\/\/doi.org\/10.1186\/s13054-018-2164-0","journal-title":"Crit Care"},{"key":"2072_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/hypertensionaha.120.15082","volume":"75","author":"AHJ Danser","year":"2020","unstructured":"Danser AHJ, Epstein M, Batlle D (2020) Renin-angiotensin system blockers and the COVID-19 pandemic. Hypertension 75:1\u20134. https:\/\/doi.org\/10.1161\/hypertensionaha.120.15082","journal-title":"Hypertension"},{"key":"2072_CR43","doi-asserted-by":"publisher","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell:1\u201310. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"2072_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30116-8","volume":"8","author":"L Fang","year":"2020","unstructured":"Fang L, Karakiulakis G, Roth M (2020) Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med 8:e21. https:\/\/doi.org\/10.1016\/S2213-2600(20)30116-8","journal-title":"Lancet Respir Med"},{"key":"2072_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-020-00240-0","volume":"7","author":"YR Guo","year":"2020","unstructured":"Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY et al (2020) The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 7:11. https:\/\/doi.org\/10.1186\/s40779-020-00240-0","journal-title":"Mil Med Res"},{"key":"2072_CR46","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Speciality Collaboration, UK (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"2072_CR47","doi-asserted-by":"publisher","unstructured":"Wan S, Yi Q, Fan S et al (2020) Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). MedRxiv. https:\/\/doi.org\/10.1101\/2020.02.10.20021832","DOI":"10.1101\/2020.02.10.20021832"},{"key":"2072_CR48","doi-asserted-by":"publisher","unstructured":"Poyiadji N, Shahin G, Noujaim D et al (2020) COVID-19\u2013associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology:201187. https:\/\/doi.org\/10.1148\/radiol.2020201187","DOI":"10.1148\/radiol.2020201187"},{"key":"2072_CR49","doi-asserted-by":"publisher","first-page":"107602962091830","DOI":"10.1177\/1076029620918308","volume":"26","author":"B Joob","year":"2020","unstructured":"Joob B, Wiwanitkit V (2020) Hemorrhagic problem among the patients with COVID-19: clinical summary of 41 Thai infected patients. Clin Appl Thromb Hemost 26:1076029620918308. https:\/\/doi.org\/10.1177\/1076029620918308","journal-title":"Clin Appl Thromb Hemost"},{"key":"2072_CR50","doi-asserted-by":"publisher","unstructured":"Pleasure SJ, Green AJ, Josephson SA (2020) The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection: neurologists move to the frontlines. JAMA Neurol. 77(6):679-680. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1065","DOI":"10.1001\/jamaneurol.2020.1065"},{"key":"2072_CR51","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/jth.14828","volume":"18","author":"J Wang","year":"2020","unstructured":"Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, Yaffe MB, Moore HB et al (2020) Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series. J Thromb Haemost 18:1752\u20131755. https:\/\/doi.org\/10.1111\/jth.14828","journal-title":"J Thromb Haemost"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02072-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-020-02072-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-020-02072-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:22:15Z","timestamp":1629332535000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-020-02072-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,19]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2072"],"URL":"https:\/\/doi.org\/10.1007\/s12035-020-02072-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2020,8,19]]},"assertion":[{"value":"12 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}